Metritrack designs and develops the technology for precise breast mapping in ultrasound and other types of breast images. Precise tissue localization in images of the deformed breast is essential for breast cancer care. First commercial product, BVN G-1000, received the FDA clearance and can easily integrate with existing ultrasound machines. The technology is well positioned for licensing or acquisition by the large imaging manufacturers.